Sofosbuvir(400mg)+Velpatasvir(100mg)

Sofosbuvir(400mg)+Velpatasvir(100mg) tablets are a highly effective antiviral combination used for the treatment of chronic Hepatitis C virus (HCV) infection. Hepatitis C is a viral liver disease that can cause serious complications such as liver cirrhosis, liver failure, and liver cancer if left untreated. This combination therapy works by targeting different stages of the viral replication process, helping to eliminate the virus from the body and improve liver health.

Sofosbuvir is a nucleotide polymerase inhibitor that blocks the virus from multiplying, while velpatasvir is an NS5A inhibitor that prevents the virus from spreading within liver cells. Together, these two powerful antiviral agents provide a pan-genotypic treatment option, meaning they are effective against multiple genotypes of the Hepatitis C virus. This combination is widely prescribed because of its high cure rates and strong safety profile when used as directed by a healthcare professional.

Sofosbuvir and Velpatasvir Tablets are manufactured according to strict pharmaceutical quality standards to ensure safety and effectiveness. When taken consistently as prescribed, the medication helps many patients achieve sustained virologic response (SVR), where the virus becomes undetectable in the bloodstream. This therapy plays a crucial role in managing Hepatitis C infection and protecting long-term liver health.

Product Features

• Combination of Sofosbuvir 400mg and Velpatasvir 100mg
• Used for the treatment of chronic Hepatitis C infection
• Pan-genotypic antiviral therapy is effective against multiple HCV genotypes
• Helps block viral replication and spread in liver cells
• High cure rates when taken as prescribed

How It Helps

• Helps eliminate the Hepatitis C virus from the body
• Reduces viral load in the bloodstream
• Prevents further liver damage and complications
• Supports long-term liver health and recovery